
# Hypothesis title

**Hypothesis ID:** d885e77587896f3397f4200e25af4da31b467726a9ea9e6af8189e42cac7b842

**Subgraph ID:** ca2e795f3a0f135cb586b88fd6d91751e0807bb3227fa468ebd3308a380e3596

Hypothesis statement

## References


## Context
None

## Subgraph
```
(`Bridge Therapy`)-[:`is often used to manage`]->(`acute flares in rheumatoid arthritis`),
(`acute flares in rheumatoid arthritis`)-[:`are characterized by elevated levels of`]->(`C-reactive protein`),
(`C-reactive protein`)-[:`can induce`]->(`monocyte activation`),
(`monocyte activation`)-[:`leads to the production of`]->(`pro-inflammatory cytokines`),
(`pro-inflammatory cytokines`)-[:`stimulate the expression of`]->(`matrix metalloproteinases`),
(`matrix metalloproteinases`)-[:`are involved in the degradation of`]->(`extracellular matrix components`),
(`extracellular matrix components`)-[:`regulate the activity of`]->(`fibroblast-like synoviocytes in rheumatoid arthritis joints`),
(`matrix metalloproteinases`)-[:`modulate the dynamics of`]->(`monocyte activation`),
(`matrix metalloproteinases`)-[:`could amplify damage during`]->(`acute flares in rheumatoid arthritis`),
(`pro-inflammatory cytokines`)-[:`interact with`]->(`extracellular matrix components`),
(`pro-inflammatory cytokines`)-[:`can indirectly affect`]->(`bridge therapy effectiveness`),
(`extracellular matrix components`)-[:`influence the persistence of`]->(`acute flares in rheumatoid arthritis`),
(`fibroblast-like synoviocytes in rheumatoid arthritis joints`)-[:`produce and secrete`]->(`pro-inflammatory cytokines`),
(`fibroblast-like synoviocytes in rheumatoid arthritis joints`)-[:`are responsive to changes in`]->(`C-reactive protein levels`),
(`C-reactive protein`)-[:`can enhance activity of`]->(`fibroblast-like synoviocytes in rheumatoid arthritis joints`),
(`acute flares in rheumatoid arthritis`)-[:`result in increased expression of`]->(`matrix metalloproteinases`),
(`monocyte activation`)-[:`can trigger`]->(`bridge therapy adjustments`)
```
